These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21246697)

  • 1. Gephyronic acid, a missing link between polyketide inhibitors of eukaryotic protein synthesis (part II): Total synthesis of gephyronic acid.
    Anderl T; Nicolas L; Münkemer J; Baro A; Sasse F; Steinmetz H; Jansen R; Höfle G; Taylor RE; Laschat S
    Angew Chem Int Ed Engl; 2011 Jan; 50(4):942-5. PubMed ID: 21246697
    [No Abstract]   [Full Text] [Related]  

  • 2. Gephyronic acid, a missing link between polyketide inhibitors of eukaryotic protein synthesis (part I): Structural revision and stereochemical assignment of gephyronic acid.
    Nicolas L; Anderl T; Sasse F; Steinmetz H; Jansen R; Höfle G; Laschat S; Taylor RE
    Angew Chem Int Ed Engl; 2011 Jan; 50(4):938-41. PubMed ID: 21246696
    [No Abstract]   [Full Text] [Related]  

  • 3. Elucidation of gephyronic acid biosynthetic pathway revealed unexpected SAM-dependent methylations.
    Young J; Stevens DC; Carmichael R; Tan J; Rachid S; Boddy CN; Müller R; Taylor RE
    J Nat Prod; 2013 Dec; 76(12):2269-76. PubMed ID: 24298873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tedanolide and the evolution of polyketide inhibitors of eukaryotic protein synthesis.
    Taylor RE
    Nat Prod Rep; 2008 Oct; 25(5):854-61. PubMed ID: 18820754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gephyronic acid, a novel inhibitor of eukaryotic protein synthesis from Archangium gephyra (myxobacteria). Production, isolation, physico-chemical and biological properties, and mechanism of action.
    Sasse F; Steinmetz H; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1995 Jan; 48(1):21-5. PubMed ID: 7868385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Basis for Olefin Rearrangement in the Gephyronic Acid Polyketide Synthase.
    Dodge GJ; Ronnow D; Taylor RE; Smith JL
    ACS Chem Biol; 2018 Sep; 13(9):2699-2707. PubMed ID: 30179448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Methylation follows condensation in the gephyronic acid modular polyketide synthase.
    Wagner DT; Stevens DC; Mehaffey MR; Manion HR; Taylor RE; Brodbelt JS; Keatinge-Clay AT
    Chem Commun (Camb); 2016 Jul; 52(57):8822-5. PubMed ID: 27346052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on the mode of action of gephyronic acid, an inhibitor of eukaryotic protein translation from myxobacteria.
    Muthukumar Y; Münkemer J; Mathieu D; Richter C; Schwalbe H; Steinmetz H; Kessler W; Reichelt J; Beutling U; Frank R; Büssow K; van den Heuvel J; Brönstrup M; Taylor RE; Laschat S; Sasse F
    PLoS One; 2018; 13(7):e0201605. PubMed ID: 30063768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereochemical determination of thuggacins A-C, highly active antibiotics from the myxobacterium Sorangium cellulosum.
    Bock M; Buntin K; Müller R; Kirschning A
    Angew Chem Int Ed Engl; 2008; 47(12):2308-11. PubMed ID: 18275054
    [No Abstract]   [Full Text] [Related]  

  • 10. Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD.
    Strancar K; Blanot D; Gobec S
    Bioorg Med Chem Lett; 2006 Jan; 16(2):343-8. PubMed ID: 16271472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of simplified tedanolide analogues--connecting tedanolide to myriaporone and gephyronic acid.
    Diaz N; Naini A; Muthukumar Y; Sasse F; Kalesse M
    ChemMedChem; 2012 May; 7(5):771-5. PubMed ID: 22383258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH.
    Watkins WJ; Chen JM; Cho A; Chong L; Collins N; Fardis M; Huang W; Hung M; Kirschberg T; Lee WA; Liu X; Thomas W; Xu J; Zeynalzadegan A; Zhang J
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3479-83. PubMed ID: 16621550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the peptidylglycine alpha-hydroxylating monooxygenase active site with novel 4-phenyl-3-butenoic acid based inhibitors.
    Langella E; Pierre S; Ghattas W; Giorgi M; Réglier M; Saviano M; Esposito L; Hardré R
    ChemMedChem; 2010 Sep; 5(9):1568-76. PubMed ID: 20715282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors.
    Bingham AH; Davenport RJ; Fosbeary R; Gowers L; Knight RL; Lowe C; Owen DA; Parry DM; Pitt WR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3622-7. PubMed ID: 18501602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-modular polyketide synthases in myxobacteria.
    Li Y; Müller R
    Phytochemistry; 2009; 70(15-16):1850-7. PubMed ID: 19586645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of new bifunctional inhibitors of type II dehydroquinase.
    Toscano MD; Stewart KA; Coggins JR; Lapthorn AJ; Abell C
    Org Biomol Chem; 2005 Sep; 3(17):3102-4. PubMed ID: 16106291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.
    Minkkilä A; Saario SM; Käsnänen H; Leppänen J; Poso A; Nevalainen T
    J Med Chem; 2008 Nov; 51(22):7057-60. PubMed ID: 18983140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylimidazole derivatives as specific inhibitors of bacterial enoyl-acyl carrier protein reductase FabK.
    Ozawa T; Kitagawa H; Yamamoto Y; Takahata S; Iida M; Osaki Y; Yamada K
    Bioorg Med Chem; 2007 Dec; 15(23):7325-36. PubMed ID: 17892940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel synthesis and in vitro activity of novel anthranilic hydroxamate-based inhibitors of the prostaglandin H2 synthase peroxidase activity.
    Lee J; Chubb AJ; Moman E; McLoughlin BM; Sharkey CT; Kelly JG; Nolan KB; Devocelle M; Fitzgerald DJ
    Org Biomol Chem; 2005 Oct; 3(20):3678-85. PubMed ID: 16211102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total synthesis, NMR solution structure, and binding model of the potent histone deacetylase inhibitor FR235222.
    Rodriquez M; Terracciano S; Cini E; Settembrini G; Bruno I; Bifulco G; Taddei M; Gomez-Paloma L
    Angew Chem Int Ed Engl; 2006 Jan; 45(3):423-7. PubMed ID: 16311994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.